125 related articles for article (PubMed ID: 10588961)
1. Differential determination of phospholipase A(2) and PAF-acetylhydrolase in biological fluids using fluorescent substrates.
Kitsiouli EI; Nakos G; Lekka ME
J Lipid Res; 1999 Dec; 40(12):2346-56. PubMed ID: 10588961
[TBL] [Abstract][Full Text] [Related]
2. HPLC-fluorimetric assay of phospholipase A2. Application to biological samples with high protein content and various reaction conditions.
Karkabounas A; Kitsiouli EI; Nakos G; Lekka ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1557-64. PubMed ID: 21511545
[TBL] [Abstract][Full Text] [Related]
3. Measurement of phospholipase A2 and 1-alkylglycerophosphocholine acetyltransferase activities in stimulated alveolar macrophages by HPLC analysis of NBD-labeled ether lipids.
Kleuser B; Meister A; Sternfeld L; Gercken G
Chem Phys Lipids; 1996 Jan; 79(1):29-37. PubMed ID: 8907240
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
Triggiani M; De Marino V; Sofia M; Faraone S; Ambrosio G; Carratù L; Marone G
Am J Respir Crit Care Med; 1997 Jul; 156(1):94-100. PubMed ID: 9230731
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B
Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174
[TBL] [Abstract][Full Text] [Related]
6. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
[TBL] [Abstract][Full Text] [Related]
7. Interfacial activation of porcine pancreatic phospholipase A(2) studied with 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled lipids.
Morales R; Fernández MS
Arch Biochem Biophys; 2002 Feb; 398(2):221-8. PubMed ID: 11831853
[TBL] [Abstract][Full Text] [Related]
8. Immobilization of Lipid Substrates: Application on Phospholipase A2 Determination.
Karkabounas A; Georgiadou DG; Argitis P; Psycharis V; Nakos G; Kosmas AM; Lekka ME
Lipids; 2015 Dec; 50(12):1259-71. PubMed ID: 26449236
[TBL] [Abstract][Full Text] [Related]
9. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
10. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
Steinbrecher UP; Pritchard PH
J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
[TBL] [Abstract][Full Text] [Related]
12. The use of C6-NBD-PC for assaying phospholipase A2-activity: scope and limitations.
Meyuhas D; Yedgar S; Rotenberg M; Reisfeld N; Lichtenberg D
Biochim Biophys Acta; 1992 Mar; 1124(3):223-32. PubMed ID: 1576162
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome.
Grissom CK; Orme JF; Richer LD; McIntyre TM; Zimmerman GA; Elstad MR
Crit Care Med; 2003 Mar; 31(3):770-5. PubMed ID: 12626982
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage alterations in pulmonary embolism.
Nakos G; Kitsiouli EI; Lekka ME
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1504-10. PubMed ID: 9817700
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
16. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F
Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney.
Antonopoulou S; Demopoulos CA; Iatrou C; Moustakas G; Zirogiannis P
Int J Biochem; 1994 Sep; 26(9):1157-62. PubMed ID: 7988740
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
[TBL] [Abstract][Full Text] [Related]
19. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
Suzuki Y; Miwa M; Harada M; Matsumoto M
Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757
[TBL] [Abstract][Full Text] [Related]
20. Acrylyl-PAF, a synthetic platelet-activating factor analogue.
Duffy-Krywicki RH; Steinhelper ME; Olson MS
J Lipid Mediat; 1991; 3(3):345-59. PubMed ID: 1773032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
